Orphalan
Works in Genetic & rare · GI & liver · Metabolic & endocrine · Neurology
Orphalan is a clinical trial sponsor. It has 2 active clinical trials with 538 planned participants, in Genetic & rare, GI & liver, Metabolic & endocrine and Neurology. Since 2021 it has completed 4 trials and stopped 0 early.
Trial track record · since 2021
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about Orphalan
Orphalan is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 538 planned participants, in Genetic & rare, GI & liver, Metabolic & endocrine, Neurology. Since 2021 it has completed 4 trials and stopped 0 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Orphalan; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-15.
Approve Suite is not affiliated with Orphalan.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.